Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use

Prostate Cancer and Prostatic Diseases volume 13, pages 132–137 (2010)Cite this article

Subjects

Abstract

The objective of this study was to report on technical incidents and early and late complications occurring in high-intensity focused ultrasound (HIFU) treatment of patients with localized prostate cancer. We performed a retrospective review of patients who were treated by Ablatherm at our centre. We recorded all technical incidents, treatment discontinuations and early (<1 month) and late complications. A total of 74 HIFU procedures were performed in 65 patients (55 first-line HIFU treatments and 10 cases of salvage therapy after radiotherapy) over a 5-year period. Median follow-up was 41 months (10–64 months). All the procedures were well tolerated and no intra- or peri-operative deaths occurred. Six technical incidents in the overall population (8.1%) led to discontinuation of the procedure. The early complication rate in patients undergoing first-line HIFU was 36.4%: urinary retention (20%), dysuria (5.4%), urinary infection (3.6%), haematuria (3.6%) and urethral stenosis (3.6%). The late complication rate was 12.7%: urethral stenosis (9%) and dysuria (3.6%). There were no cases of rectourethral fistula. The long-term urinary incontinence rate was 20% and the de novo erectile dysfunction rate was 77.1%. Nine complications (16.4%) required surgical management. The overall complication rate was 49%. Ablatherm is a reliable technique with a relatively high complication rate. However, most complications were minor and required surgical management in a few cases only. Our results confirm that all patients who are offered HIFU treatment should be properly informed of the risks, in particular with regard to continence and sexual function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Thüroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A et al. High-intensity focused ultrasound and localized prostate cancer: efficacity results from the European multicentric study. J Endourol 2003; 17: 673–677.

    Article  Google Scholar 

  2. Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF et al. Eight years’ experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. J Urol 2008; 72: 1329–1334.

    Article  Google Scholar 

  3. Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R, Martin X et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51: 381–387.

    Article  CAS  Google Scholar 

  4. Pasticier G, Chapet O, Badet L, Ardiet JM, Poissonnier L, Murat FJ et al. Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results. Urology 2008; 72: 1305–1309.

    Article  CAS  Google Scholar 

  5. Zacharakis E, Ahmed HU, Ishaq A, Scott R, Illing R, Freeman A et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int 2008; 102: 786–792.

    Article  Google Scholar 

  6. Challacombe BJ, Murphy DG, Zakri R, Cahill DJ . High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-years follow-up. BJU Int 2009; 104: 200–204.

    Article  Google Scholar 

  7. Coulange C . High intensity focused ultrasound in localized prostate cancer. Cancer Radiother 2005; 9: 377–378.

    Article  Google Scholar 

  8. Soulié M, Beuzeboc P, Cornud F, Eschwege P, Gaschignard N, Grosclaude P et al. Recommandations 2007 en onco-urologie. Prog Urol 2007; 17: 1157–1188.

    Article  Google Scholar 

  9. Ingelman-Sundberg A . Urinary incontinence in women. Nord Med 1953; 50: 1751–1752.

    CAS  Google Scholar 

  10. Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option. Eur Urol 2008; 55: 640–649.

    Article  Google Scholar 

  11. Chalasani V, Martinez CH, Lim D, Chin J . Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis 2009; 12: 124–129.

    Article  CAS  Google Scholar 

  12. Colombel M, Gelet A . Principles and results of high-intensity focused ultrasound for localized prostate cancer. Prostate Cancer Prostatic Dis 2004; 7: 289–294.

    Article  CAS  Google Scholar 

  13. Ahmed HU, Ishaq A, Zacharakis E, Shaw G, Illing R, Allen C et al. Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy. BJU Int 2009; 103: 321–323.

    Article  Google Scholar 

  14. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C et al. First analysis of the long-term result with transrectal HIFU in patients with localized prostate cancer. Eur Urol 2008; 53: 1194–1201.

    Article  Google Scholar 

  15. Lee HM, Hong JH, Choi HY . High-intensity focused ultrasound therapy for clinically localized prostate cancer. Prostate Cancer Prostatic Dis 2006; 9: 439–443.

    Article  CAS  Google Scholar 

  16. Chaussy C, Thüroff S . The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248–252.

    Article  Google Scholar 

  17. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F . Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 2004; 171: 2265–2267.

    Article  Google Scholar 

  18. Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B et al. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008; 71: 863–867.

    Article  Google Scholar 

  19. Blana A, Walter B, Rogenhofer S, Wieland WF . High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-years experience. Urology 2004; 63: 297–300.

    Article  Google Scholar 

  20. Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006; 13: 228–233.

    Article  Google Scholar 

  21. Ficarra V, Antoniolli SZ, Novara G, Parisi A, Fracalanza S, Martignoni G et al. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. BJU Int 2006; 98: 1193–1198.

    Article  Google Scholar 

  22. Poissonnier L, Gelet A, Chapelon JY, Bouvier R, Rouviere O, Pangaud C et al. Result of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA &lt;or+10 ng/ml). Prog Urol 2003; 13: 60–72.

    PubMed  Google Scholar 

  23. Murat FJ, Poissonnier MD, Pasticier G, Gelet A . High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control 2007; 14: 244–249.

    Article  Google Scholar 

  24. Rebillard X, Soulié M, Chartier-Kastler E, Davin JL, Mignard JP, Moreau JL et al. High-intensity focused ultrasound in prostate cancer: a systematic literature review of the French Association of Urology. BJU Int 2008; 101: 1205–1213.

    Article  Google Scholar 

  25. Uchida T, Ohkusa H, Yasunori N, Hyodo T, Satoh T, Irie A . Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 2006; 97: 56–61.

    Article  Google Scholar 

  26. Chaussy C, Thüroff S . Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001; 15: 437–440.

    Article  CAS  Google Scholar 

  27. Chaussy C, Thüroff S . High-intensity focused ultrasound in prostate cancer: results after 3 years. Mol Urol 2000; 4: 179–182.

    CAS  PubMed  Google Scholar 

  28. Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B . Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol 2006; 24: 585–590.

    Article  Google Scholar 

  29. Chen L, Ter Haar HG, Hill CR . Influence of ablated tissue on the formation of high-intensity focused ultrasound lesions. Ultrasound Med Biol 1997; 6: 921–931.

    Article  Google Scholar 

  30. Curiel L, Chavrier F, Gignoux B, Pichardo S, Chesnais S, Chapelon JY . Experimental evaluation of lesion prediction modelling in the presence of cavitation bubbles: intended for high-intensity focused ultrasound prostate treatment. Med Biol Eng Comput 2004; 42: 44–54.

    Article  CAS  Google Scholar 

  31. Heidenreich A, Bolla M, Joniau S, van der Kwast TH, Matveev V, Mason MD et al. European Association of Urology–Guidelines on Prostate Cancer. 2009, p 72–73.

  32. Tsakiris P, Thüroff S, de la Rosette J, Chaussy C . Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. J Endourol 2008; 22: 221–229.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology and Andrology, CHU Reims, Reims, France

    T Ripert, M-D Azémar, J Ménard, Y Bayoud, R Messaoudi, F Duval & F Staerman

Authors
  1. T Ripert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M-D Azémar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Ménard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Bayoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Messaoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Duval
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F Staerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Ripert.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ripert, T., Azémar, MD., Ménard, J. et al. Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use. Prostate Cancer Prostatic Dis 13, 132–137 (2010). https://doi.org/10.1038/pcan.2009.57

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2009.57

Keywords

Search

Advanced search

Quick links